Correlation Between Travere Therapeutics and Eton Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Travere Therapeutics and Eton Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Travere Therapeutics and Eton Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Travere Therapeutics and Eton Pharmaceuticals, you can compare the effects of market volatilities on Travere Therapeutics and Eton Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Travere Therapeutics with a short position of Eton Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Travere Therapeutics and Eton Pharmaceuticals.

Diversification Opportunities for Travere Therapeutics and Eton Pharmaceuticals

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Travere and Eton is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Travere Therapeutics and Eton Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eton Pharmaceuticals and Travere Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Travere Therapeutics are associated (or correlated) with Eton Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eton Pharmaceuticals has no effect on the direction of Travere Therapeutics i.e., Travere Therapeutics and Eton Pharmaceuticals go up and down completely randomly.

Pair Corralation between Travere Therapeutics and Eton Pharmaceuticals

Given the investment horizon of 90 days Travere Therapeutics is expected to generate 15.79 times less return on investment than Eton Pharmaceuticals. But when comparing it to its historical volatility, Travere Therapeutics is 1.32 times less risky than Eton Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Eton Pharmaceuticals is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  819.00  in Eton Pharmaceuticals on August 25, 2024 and sell it today you would earn a total of  304.00  from holding Eton Pharmaceuticals or generate 37.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Travere Therapeutics  vs.  Eton Pharmaceuticals

 Performance 
       Timeline  
Travere Therapeutics 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Travere Therapeutics are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Travere Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Eton Pharmaceuticals 

Risk-Adjusted Performance

29 of 100

 
Weak
 
Strong
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eton Pharmaceuticals are ranked lower than 29 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Eton Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Travere Therapeutics and Eton Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Travere Therapeutics and Eton Pharmaceuticals

The main advantage of trading using opposite Travere Therapeutics and Eton Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Travere Therapeutics position performs unexpectedly, Eton Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eton Pharmaceuticals will offset losses from the drop in Eton Pharmaceuticals' long position.
The idea behind Travere Therapeutics and Eton Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets